Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

NASDAQ:TOUR - Nasdaq - US89977P1066 - ADR - Currency: USD

0.8561  -0.02 (-2.16%)

Premarket: 0.855 0 (-0.13%)

Fundamental Rating

5

Taking everything into account, TOUR scores 5 out of 10 in our fundamental rating. TOUR was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. TOUR has only an average score on both its financial health and profitability. TOUR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TOUR was profitable.
In the past year TOUR had a positive cash flow from operations.
In the past 5 years TOUR reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: TOUR reported negative operating cash flow in multiple years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

TOUR's Return On Assets of 4.03% is fine compared to the rest of the industry. TOUR outperforms 62.60% of its industry peers.
With a decent Return On Equity value of 7.12%, TOUR is doing good in the industry, outperforming 64.12% of the companies in the same industry.
TOUR has a Return On Invested Capital (6.07%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROIC 6.07%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

TOUR has a better Profit Margin (14.98%) than 88.55% of its industry peers.
TOUR has a Operating Margin of 15.18%. This is in the better half of the industry: TOUR outperforms 67.18% of its industry peers.
With an excellent Gross Margin value of 69.65%, TOUR belongs to the best of the industry, outperforming 84.73% of the companies in the same industry.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

6

2. Health

2.1 Basic Checks

TOUR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TOUR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TOUR has been reduced compared to 5 years ago.
The debt/assets ratio for TOUR has been reduced compared to a year ago.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

TOUR has an Altman-Z score of -4.78. This is a bad value and indicates that TOUR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.78, TOUR is doing worse than 93.89% of the companies in the same industry.
There is no outstanding debt for TOUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -4.78
ROIC/WACC0.62
WACC9.85%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
TOUR has a better Current ratio (1.35) than 68.70% of its industry peers.
A Quick Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
TOUR has a Quick ratio of 1.35. This is in the better half of the industry: TOUR outperforms 71.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

TOUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.78%, which is quite impressive.
Looking at the last year, TOUR shows a quite strong growth in Revenue. The Revenue has grown by 16.45% in the last year.
TOUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -25.77% yearly.
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%

3.2 Future

The Earnings Per Share is expected to decrease by -21.60% on average over the next years. This is quite bad
The Revenue is expected to grow by 13.31% on average over the next years. This is quite good.
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

4

4. Valuation

4.1 Price/Earnings Ratio

TOUR is valuated reasonably with a Price/Earnings ratio of 9.51.
Based on the Price/Earnings ratio, TOUR is valued cheaply inside the industry as 96.18% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.05, TOUR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 75.21, the valuation of TOUR can be described as expensive.
65.65% of the companies in the same industry are cheaper than TOUR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of TOUR to the average of the S&P500 Index (37.67), we can say TOUR is valued expensively.
Industry RankSector Rank
PE 9.51
Fwd PE 75.21
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOUR is valued a bit cheaper than 79.39% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TOUR is valued cheaply inside the industry as 96.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.6
EV/EBITDA 8.58
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TOUR's earnings are expected to decrease with -21.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%

3

5. Dividend

5.1 Amount

TOUR has a Yearly Dividend Yield of 3.31%. Purely for dividend investing, there may be better candidates out there.
TOUR's Dividend Yield is rather good when compared to the industry average which is at 3.51. TOUR pays more dividend than 86.26% of the companies in the same industry.
TOUR's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

TOUR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

TUNIU CORP-SPON ADR

NASDAQ:TOUR (7/25/2025, 8:00:01 PM)

Premarket: 0.855 0 (-0.13%)

0.8561

-0.02 (-2.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)06-02 2025-06-02
Earnings (Next)08-04 2025-08-04
Inst Owners9.95%
Inst Owner Change-0.38%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap100.77M
Analysts85.71
Price Target1.73 (102.08%)
Short Float %0.41%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.51
Fwd PE 75.21
P/S 1.41
P/FCF 8.6
P/OCF 7.53
P/B 0.67
P/tB 0.75
EV/EBITDA 8.58
EPS(TTM)0.09
EY10.51%
EPS(NY)0.01
Fwd EY1.33%
FCF(TTM)0.1
FCFY11.63%
OCF(TTM)0.11
OCFY13.29%
SpS0.61
BVpS1.28
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROCE 7.68%
ROIC 6.07%
ROICexc 6.07%
ROICexgc 6.82%
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
FCFM 16.34%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-Score8
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 192.93%
Cap/Sales 2.33%
Interest Coverage 26.17
Cash Conversion 113.99%
Profit Quality 109.09%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -4.78
F-Score8
WACC9.85%
ROIC/WACC0.62
Cap/Depr(3y)99.5%
Cap/Depr(5y)69.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A
EBIT growth 1Y477.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year526.16%
EBIT Next 3Y111.94%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A